These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prescription of hearing-aid output for tinnitus relief.
    Author: Shekhawat GS, Searchfield GD, Kobayashi K, Stinear CM.
    Journal: Int J Audiol; 2013 Sep; 52(9):617-25. PubMed ID: 23859059.
    Abstract:
    OBJECTIVE: Tinnitus is a perceived sound that cannot be attributed to an external source. This study attempts to identify a prescription of amplification that is optimized as a first-fit setting for tinnitus relief. DESIGN: Participants compared the effect of high frequency amplification on their tinnitus. Stimuli were 13 speech files with different amounts of high frequency amplification (three cut-off frequencies and four gain settings) to simulate the effects of a change in DSL(I/O) v5.0 prescription in the high frequencies. STUDY SAMPLE: Twenty-five participants with chronic tinnitus participated in the study. RESULTS: A 6-dB reduction to prescribed gain at 2 kHz emerged as the most preferred output (26.47% participants) to interfere with participants' tinnitus. Overall, 70.58% of the participants' preferred a 3 to 6 dB reduction in output while 29.42% preferred a similar increase across all cut-off frequencies. A trend was observed in which the higher the tinnitus pitch the more similar the preferred output to DSL(I/O) v5.0. CONCLUSION: DSL(I/O) v5.0 appears to be a good starting point for prescription of hearing-aid output for tinnitus management. Long-term benefits of different prescriptions for tinnitus still need to be ascertained.
    [Abstract] [Full Text] [Related] [New Search]